Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Matthew Thomas Menard, M.D.

Title
Institution
Department
Address
Phone

Research
research activities and funding
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
Most Recent  |  List All
  1. U01HL107352 (MENARD, MATTHEW THOMAS) Sep 17, 2013 - Mar 31, 2021
    NIH
    BEST-CLI Trial-CCC-Lead
    Role: Co-Principal Investigator

Bibliographic
selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
Displaying 25 of 120 total Publications Show all
  1. Malas MB, Hamouda M, Farber A, Menard MT, Conte MS, Rosenfield K, Strong MB, Doros G, Powell RJ, Mena-Hurtado C, Gasper W, Schermerhorn ML, Allievi S, Smolderen KG, Dake MD, Rymer JA, Tuttle KR. Outcomes of chronic limb-threatening ischemia revascularization in patients with chronic kidney disease in the BEST-CLI trial. J Vasc Surg. 2025 Jan 22. PMID: 39846933.
    Citations:
    Fields: GenGeneral SurgeryVasVascular Diseases
  2. Siracuse JJ, Farber A, Menard MT, Rosenfield K, Conte MS, Schanzer A, Doros G, Motaganahalli R, Laskowski IJ, Barshes NR, Genovese EA, Strong MB, Mills JL. Advanced Wound, Ischemia, and foot Infection stage is associated with poor outcomes in the BEST-CLI trial. J Vasc Surg. 2024 Dec 03. PMID: 39638100.
    Citations:
    Fields: GenGeneral SurgeryVasVascular Diseases
  3. McGinigle KL, Doros G, Alabi O, Brooke BS, Vouyouka A, Hiramoto J, Charlton-Ouw K, Strong MB, Rosenfield K, Menard MT, Farber A, Giles KA. Female patients have fewer limb amputations compared to male patients in the BEST-CLI trial. J Vasc Surg. 2025 Feb; 81(2):366-373.e1. PMID: 39368637.
    Citations:
    Fields: GenGeneral SurgeryVasVascular Diseases
  4. Ochoa Chaar CI, Malas M, Doros G, Schermerhorn M, Conte MS, Alameddine D, Siracuse JJ, Yadavalli SD, Dake MD, Creager MA, Tan TW, Rosenfield K, Menard MT, Farber A, Hamdan A. The impact of diabetes mellitus on the outcomes of revascularization for chronic limb-threatening ischemia in the BEST-CLI trial. J Vasc Surg. 2025 Feb; 81(2):376-385.e3. PMID: 39332785.
    Citations:
    Fields: GenGeneral SurgeryVasVascular Diseases
  5. Farber A, Menard MT, Conte MS, Rosenfield K, Schermerhorn M, Schanzer A, Powell RJ, Chaar CIO, Hicks CW, Doros G, Strong MB, Leers SA, Motaganahalli R, Stangenberg L, Siracuse JJ. Prosthetic conduits have worse outcomes compared with great saphenous vein conduits in femoropopliteal and infrapopliteal bypass in patients with chronic limb-threatening ischemia. J Vasc Surg. 2025 Feb; 81(2):408-416.e2. PMID: 39321895.
    Citations:
    Fields: GenGeneral SurgeryVasVascular Diseases
  6. Menard MT, Farber A, Doros G, McGinigle KL, Chisci E, Clavijo LC, Kayssi A, Schneider PA, Hawkins BM, Dake MD, Hamza T, Strong MB, Rosenfield K, Conte MS. The impact of revascularization strategy on clinical failure, hemodynamic failure, and chronic limb-threatening ischemia symptoms in the BEST-CLI Trial. J Vasc Surg. 2024 Dec; 80(6):1755-1765.e4. PMID: 39069016; PMCID: PMC11734614.
    Citations:
    Fields: GenGeneral SurgeryVasVascular Diseases
  7. Nadim B, Alizada S, Gupta S, Steigner ML, Menard MT, Aghayev A. Under pressure: a head-to-toe review of vascular compression syndromes. Clin Radiol. 2024 10; 79(10):722-735. PMID: 39107192.
    Citations:
    Fields: RadRadiologyTranslation:Humans
  8. Venermo MA, Farber A, Schanzer A, Menard MT, Rosenfield K, Dosluoglu H, Goodney PP, Abou-Zamzam AM, Motaganahalli R, Doros G, Creager MA. Editor's Choice - Reduction of Major Amputations after Surgery versus Endovascular Intervention: The BEST-CLI Randomised Trial. Eur J Vasc Endovasc Surg. 2024 Nov; 68(5):590-597. PMID: 38925339.
    Citations:
    Fields: GenGeneral SurgeryVasVascular DiseasesTranslation:Humans
  9. Heindel P, Fitzgibbon JJ, McKie K, Goudreau B, Dieffenbach BV, Aicher BO, Belkin M, Farber A, Menard MT, Hussain MA. Real-World Vein Mapping Practice Patterns Before Endovascular Treatment of Limb Ischemia. J Surg Res. 2024 Sep; 301:62-70. PMID: 38917575; PMCID: PMC11427167.
    Citations:
    Fields: GenGeneral SurgeryTranslation:Humans
  10. Giles KA, Farber A, Menard MT, Conte MS, Nolan BW, Siracuse JJ, Strong MB, Doros G, Venermo M, Azene E, Rosenfield K, Powell RJ. Surgery or endovascular therapy for patients with chronic limb-threatening ischemia requiring infrapopliteal interventions. J Vasc Surg. 2024 Nov; 80(5):1515-1524. PMID: 38908805; PMCID: PMC11633720.
    Citations: 1
    Fields: GenGeneral SurgeryVasVascular DiseasesTranslation:Humans
  11. Feliz JD, Heindel P, Fitzgibbon JJ, Ozaki CK, Gravereaux E, Nguyen LL, Menard M, Belkin M, Hussain MA. Descriptive Analysis of Amputation-Free Survival After First Time Infra-Inguinal Bypass Occlusion. J Surg Res. 2024 Aug; 300:263-271. PMID: 38824856.
    Citations:
    Fields: GenGeneral SurgeryTranslation:Humans
  12. Zarrintan S, Rahgozar S, Ross EG, Farber A, Menard MT, Conte MS, Malas MB. Endovascular therapy versus bypass for chronic limb-threatening ischemia in a real-world practice. J Vasc Surg. 2024 Oct; 80(4):1169-1181. PMID: 38718850.
    Citations:
    Fields: GenGeneral SurgeryVasVascular DiseasesTranslation:Humans
  13. Siracuse JJ, Menard MT, Rosenfield K, Conte MS, Powell R, Hamburg N, Doros G, Strong MB, Farber A. Characterization of cardiovascular serious adverse events after bypass or endovascular revascularization for limb-threatening ischemia in the BEST-CLI trial. J Vasc Surg. 2024 Sep; 80(3):774-779. PMID: 38626847.
    Citations:
    Fields: GenGeneral SurgeryVasVascular Diseases
  14. Menard MT, Farber A, Powell RJ, Rosenfield K, Conte MS, Hamza TH, Kaufman JA, Cziraky MJ, Creager MA, Dake MD, Jaff MR, Reid D, Sopko G, White CJ, Strong MB, van Over M, Chisci E, Goodney PP, Gray B, Kayssi A, Siracuse JJ, Choudhry NK, BEST-CLI Investigators. Quality of Life in Patients With Chronic Limb-Threatening Ischemia Treated With Revascularization. Circulation. 2024 Apr 16; 149(16):1241-1253. PMID: 38597097; PMCID: PMC11360227.
    Citations:
    Fields: CarCardiologyVasVascular DiseasesTranslation:Humans
  15. D'Angelo O, Menard MT, Farber A. Common Criticisms and Rebuttals of the Best Endovascular Versus Best Surgical Therapy in Patients with Chronic Limb-Threatening Ischemia (BEST-CLI) Trial. Ann Vasc Surg. 2024 Oct; 107:93-100. PMID: 38599479.
    Citations:
    Fields: GenGeneral SurgeryVasVascular DiseasesTranslation:Humans
  16. Patrone L, Pasqui E, Conte MS, Farber A, Ferraresi R, Menard M, Mills JL, Rundback J, Schneider P, Ysa A, Abhishek K, Adams GL, Ahmad N, Ahmed I, Alexandrescu VA, Amor M, Alper D, Andrassy M, Attinger C, Baadh A, Barakat H, Biasi L, Bisdas T, Bhatti Z, Blessing E, Bonaca MP, Bonvini S, Bosiers M, Bradbury AW, Beasley R, Behrendt CA, Brodmann M, Cabral G, Cancellieri R, Casini A, Chandra V, Chisci E, Chohan O, Choke ETC, Chong PFS, Clerici G, Coscas R, Costantino M, Dalla Paola L, Dand S, Davies RSM, D'Oria M, Diamantopoulos A, Debus S, Deloose K, Del Giudice C, Donato G, Rubertis B, Paul De Vries J, Dias NV, Diaz-Sandoval L, Dick F, Donas K, Dua A, Fanelli F, Fazzini S, Foteh M, Gandini R, Gargiulo M, Garriboli L, Genovese EA, Gifford E, Goueffic Y, Goverde P, Chand Gupta P, Hinchliffe R, Holden A, Houlind KC, Howard DP, Huasen B, Isernia G, Katsanos K, Katzen B, Kolh P, Koncar I, Korosoglou G, Krishnan P, Kroencke T, Krokidis M, Kumarasamy A, Hayes P, Iida O, Alejandre Lafont E, Langhoff R, Lecis A, Lessne M, Lichaa H, Lichtenberg M, Lobato M, Lopes A, Loreni G, Lucatelli P, Madassery S, Maene L, Manzi M, Maresch M, Santhosh Mathews J, McCaslin J, Micari A, Michelagnoli S, Migliara B, Morgan R, Morelli L, Morosetti D, Mouawad N, Moxey P, Müller-Hülsbeck S, Mustapha J, Nakama T, Nasr B, N'dandu Z, Neville R, Noory E, Nordanstig J, Noronen K, Mariano Palena L, Parlani G, Patel AS, Patel P, Patel R, Patel S, Pena C, Perkov D, Portou M, Pratesi G, Rammos C, Reekers J, Riambau V, Roy T, Rosenfield K, Antonella Ruffino M, Saab F, Saratzis A, Sbarzaglia P, Schmidt A, Secemsky E, Siah M, Sillesen H, Simonte G, Sirvent M, Sommerset J, Steiner S, Sakr A, Scheinert D, Shishebor M, Spiliopoulos S, Spinelli A, Stravoulakis K, Taneva G, Teso D, Tessarek J, Theivacumar S, Thomas A, Thomas S, Thulasidasan N, Torsello G, Tripathi R, Troisi N, Tummala S, Tummala V, Twine C, Uberoi R, Ucci A, Valenti D, van den Berg J, van den Heuvel D, Van Herzeele I, Varcoe R, Vega de Ceniga M, Veith FJ, Venermo M, Vijaynagar B, Virdee S, Von Stempel C, Voûte MT, Khee Yeung K, Zeller T, Zayed H, Montero Baker M. The "Woundosome" Concept and Its Impact on Procedural Outcomes in Patients With Chronic Limb-Threatening Ischemia. J Endovasc Ther. 2024 Mar 25; 15266028241231745. PMID: 38523459.
    Citations:
    Fields: VasVascular Diseases
  17. Conte MS, Azene E, Doros G, Gasper WJ, Hamza T, Kashyap VS, Guzman R, Mena-Hurtado C, Menard MT, Rosenfield K, Rowe VL, Strong M, Farber A. Secondary interventions following open vs endovascular revascularization for chronic limb threatening ischemia in the BEST-CLI trial. J Vasc Surg. 2024 Jun; 79(6):1428-1437.e4. PMID: 38368997.
    Citations:
    Fields: GenGeneral SurgeryVasVascular DiseasesTranslation:Humans
  18. Nordanstig J, Menard MT. Do We Lose on the Swings What We Gain on the Roundabouts? Eur J Vasc Endovasc Surg. 2024 Jul; 68(1):108-109. PMID: 38360132.
    Citations:
    Fields: GenGeneral SurgeryVasVascular Diseases
  19. Farber A, Menard MT, Bonaca MP, Bradbury A, Conte MS, Debus ES, Eldrup N, Goodney P, Gupta PC, Hinchliffe RJ, Houlind KC, Kolh P, Kum SWC, Nordanstig J, Parikh SA, Patel MR, Patrone L, Sillesen H, Strong MB, Varcoe RL, Vega de Ceniga M, Venermo MA, Rosenfield K. BEST-CLI International Collaborative: planning a better future for patients with chronic limb-threatening ischaemia globally. Br J Surg. 2024 01 31; 111(2). PMID: 38294083; PMCID: PMC10828928.
    Citations: 1
    Fields: GenGeneral SurgeryTranslation:Humans
  20. Fitzgibbon JJ, Heindel P, Abdou M, Goudreau B, Dieffenbach BV, Aicher B, Menard MT. Contemporary outcomes of surgical decompression for functional popliteal entrapment syndrome. J Vasc Surg. 2024 Jun; 79(6):1412-1419. PMID: 38301807.
    Citations: 2
    Fields: GenGeneral SurgeryVasVascular DiseasesTranslation:Humans
  21. Bikdeli B, Sadeghipour P, Lou J, Bejjani A, Khairani CD, Rashedi S, Lookstein R, Lansky A, Vedantham S, Sobieszczyk P, Mena-Hurtado C, Aghayev A, Henke P, Mehdipoor G, Tufano A, Chatterjee S, Middeldorp S, Wasan S, Bashir R, Lang IM, Shishehbor MH, Gerhard-Herman M, Giri J, Menard MT, Parikh SA, Mazzolai L, Moores L, Monreal M, Jimenez D, Goldhaber SZ, Krumholz HM, Piazza G. Developmental or Procedural Vena Cava Interruption and Venous Thromboembolism: A Review. Semin Thromb Hemost. 2024 Sep; 50(6):851-865. PMID: 38176425.
    Citations: 1
    Fields: HemHematologyVasVascular DiseasesTranslation:Humans
  22. Farber A, Siracuse JJ, Giles K, Jones DW, Laskowski IA, Powell RJ, Rosenfield K, Strong MB, White CJ, Doros G, Menard MT. Investigator attitudes on equipoise and practice patterns in the BEST-CLI trial. J Vasc Surg. 2024 Apr; 79(4):865-874. PMID: 38056700.
    Citations:
    Fields: GenGeneral SurgeryVasVascular DiseasesTranslation:Humans
  23. Siracuse JJ, Farber A, Menard MT, Conte MS, Kaufman JA, Jaff M, Kiang SC, Ochoa Chaar CI, Osborne N, Singh N, Tan TW, Guzman RJ, Strong MB, Hamza TH, Doros G, Rosenfield K. Perioperative complications following open or endovascular revascularization for chronic limb-threatening ischemia in the BEST-CLI Trial. J Vasc Surg. 2023 10; 78(4):1012-1020.e2. PMID: 37318428.
    Citations: 1
    Fields: GenGeneral SurgeryVasVascular DiseasesTranslation:Humans
  24. McGinigle KL, Menard MT, Conte MS. Transcatheter Arterialization of Veins in Chronic Limb-Threatening Ischemia. N Engl J Med. 2023 Jun 08; 388(23):2201-2202. PMID: 37285533.
    Citations:
    Fields: MedMedicine (General)Translation:Humans
  25. Menard MT, Jaff MR, Farber A, Rosenfield K, Conte MS, White CJ, Beckman JA, Choudhry NK, Clavijo LC, Huber TS, Tuttle KR, Hamza TH, Schanzer A, Laskowski IA, Cziraky MJ, Drooz A, van Over M, Strong MB, Weinberg I. Baseline modern medical management in the BEST-CLI trial. J Vasc Surg. 2023 09; 78(3):711-718.e5. PMID: 37201761; PMCID: PMC10528824.
    Citations: 1
    Fields: GenGeneral SurgeryVasVascular DiseasesTranslation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contact@catalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resources@hms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappt@hms.harvard.edu.
Menard's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (376)
Explore
_
Co-Authors (63)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.